European equities traded in the US as American depositary receipts were heading higher late Thursday morning, rising 0.85% to 1,947.79 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and pharmaceutical company Ascendis Pharma (ASND), which advanced 4.8% and 2.2% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and internet ad firm Criteo (CRTO), which were up 1.7% and 0.9% respectively.
The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which dropped 2.3% and 2.1% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and biotech company Evaxion (EVAX), which lost 1.8% and 1.3% respectively.
The gainers from the UK were led by communications company WPP (WPP) and biotech firm Trinity Biotech (TRIB), which surged 26% and 11% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and alcoholic beverage company Diageo (DEO), which rose 5.3% and 4.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and medical device maker Smith & Nephew (SNN), which fell 4.4% and 1.9% respectively. They were followed by educational publisher Pearson (PSO) and biopharmaceutical company Mereo BioPharma Group (MREO), which were down 1.6% and 1.2% respectively.